R&R had a horrible rep with investors back then, especially in developmental biotechs... we always said, if Rodman & Renshaw initiates coverage, sell your stock FAST because a financing is coming...
I do realize that raising cash is part of the investing playbook, and if that's what MARA needs to do to be successful, then so be it.
Not that it has any relevance whatsoever to Marathon, but you are correct. I believe some of the Rodman guys went to Wainright, while others went to Dawson James.
Market Data 
Markets 
AI
